JP2004532828A5 - - Google Patents

Download PDF

Info

Publication number
JP2004532828A5
JP2004532828A5 JP2002572952A JP2002572952A JP2004532828A5 JP 2004532828 A5 JP2004532828 A5 JP 2004532828A5 JP 2002572952 A JP2002572952 A JP 2002572952A JP 2002572952 A JP2002572952 A JP 2002572952A JP 2004532828 A5 JP2004532828 A5 JP 2004532828A5
Authority
JP
Japan
Prior art keywords
tramadol
pharmaceutical composition
milligrams
cis
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002572952A
Other languages
English (en)
Other versions
JP2004532828A (ja
JP4377585B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/007928 external-priority patent/WO2002074241A2/en
Publication of JP2004532828A publication Critical patent/JP2004532828A/ja
Publication of JP2004532828A5 publication Critical patent/JP2004532828A5/ja
Application granted granted Critical
Publication of JP4377585B2 publication Critical patent/JP4377585B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Claims (14)

  1. 有効量のトラマドール物質を含んでなる射精遅延のための医薬組成物。
  2. 前記トラマドール物質はトラマドール又は医薬として許容可能なトラマドールの塩である請求項１に記載の医薬組成物。
  3. 前記トラマドール物質は（±）シス‐トラマドール又は医薬として許容可能な（±）シス‐トラマドールの塩である請求項２に記載の医薬組成物。
  4. 約１０ミリグラムから約５０ミリグラムの量の前記トラマドール又は前記医薬として許容可能な（±）シス‐トラマドールの塩を含んでなる請求項３に記載の医薬組成物。
  5. 約１５ミリグラムから約３５ミリグラムの量の前記トラマドール又は前記医薬として許容可能な（±）シス‐トラマドールの塩を含んでなる請求項４に記載の医薬組成物。
  6. 約２５ミリグラムの量の前記トラマドール又は前記医薬として許容可能な（±）シス‐トラマドールの塩を含んでなる請求項５に記載の医薬組成物。
  7. 前記シス‐トラマドールの、又は前記医薬として許容可能なシス‐トラマドールの塩の（＋）光学異性体を含んでなる請求項３に記載の医薬組成物。
  8. 前記シス‐トラマドールの、又は前記医薬として許容可能なシス‐トラマドールの塩の（−）光学異性体を含んでなる請求項３に記載の医薬組成物。
  9. 前記トラマドール物質は塩酸（±）シス‐トラマドールである請求項３に記載の医薬組成物。
  10. 約１０ミリグラムから約５０ミリグラムの量の前記塩酸トラマドールを含んでなる請求項９に記載の医薬組成物。
  11. 約１５ミリグラムから約３５ミリグラムの量の前記塩酸トラマドールを含んでなる請求
    項１０に記載の医薬組成物。
  12. 約２５ミリグラムの量の前記塩酸トラマドールを含んでなる請求項１１に記載の医薬組成物。
  13. 経口投与されることを特徴とする請求項１乃至請求項１２のいずれか１項に記載の医薬組成物。
  14. 早漏を治療するための請求項１乃至請求項１３のいずれか１項に記載の医薬組成物。
JP2002572952A 2001-03-16 2002-03-15 射精遅延の方法 Expired - Fee Related JP4377585B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27680601P 2001-03-16 2001-03-16
PCT/US2002/007928 WO2002074241A2 (en) 2001-03-16 2002-03-15 Method of delaying ejaculation

Publications (3)

Publication Number Publication Date
JP2004532828A JP2004532828A (ja) 2004-10-28
JP2004532828A5 true JP2004532828A5 (ja) 2006-01-05
JP4377585B2 JP4377585B2 (ja) 2009-12-02

Family

ID=23058139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002572952A Expired - Fee Related JP4377585B2 (ja) 2001-03-16 2002-03-15 射精遅延の方法

Country Status (18)

Country Link
US (2) US6974839B2 (ja)
EP (1) EP1397126B9 (ja)
JP (1) JP4377585B2 (ja)
KR (1) KR100908350B1 (ja)
CN (1) CN1289071C (ja)
AT (1) ATE326957T1 (ja)
AU (1) AU2002252361C1 (ja)
CA (2) CA2758923A1 (ja)
CY (1) CY1107478T1 (ja)
DE (1) DE60211689T2 (ja)
DK (1) DK1397126T5 (ja)
ES (1) ES2265495T3 (ja)
HK (1) HK1068549A1 (ja)
MX (1) MXPA03008372A (ja)
NZ (1) NZ528935A (ja)
PT (1) PT1397126E (ja)
WO (1) WO2002074241A2 (ja)
ZA (1) ZA200308067B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289071C (zh) * 2001-03-16 2006-12-13 Dmi生物科学公司 曲马朵物质在制备用于延缓男性射精的药物中的用途
AU2003214800A1 (en) 2002-01-02 2003-07-24 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
AU2003291302A1 (en) * 2002-11-06 2004-06-03 Azaya Therapeutics, Inc. Method for treatment of premature ejaculation in humans
WO2004078143A2 (en) * 2003-03-05 2004-09-16 The Brigham And Women's Hospital Inc. Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
US8841345B2 (en) 2003-03-21 2014-09-23 Nexmed Holdings, Inc. Compositions and methods for treatment of premature ejaculation
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
US8604082B2 (en) * 2005-12-13 2013-12-10 Trinity Laboratories, Inc. Method to treat premature ejaculation in humans
FR2907121B1 (fr) 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
MX2009008511A (es) * 2007-02-12 2010-01-20 Dmi Biosciences Inc Reduccion de efectos secundarios de tramadol.
KR20140054312A (ko) * 2007-02-12 2014-05-08 디엠아이 바이오사이언시스 인코포레이티드 조루 및 발기부전을 동시에 치료하는 방법
US20100120780A1 (en) * 2007-04-19 2010-05-13 Chandra Ulagaraj Singh Treatments for premature ejaculation in humans
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
KR101103118B1 (ko) * 2007-11-02 2012-01-04 동아제약주식회사 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
GR1007315B (el) * 2010-04-19 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Υγρομορφη παρεντερικης χορηγησης συνθεση που περιλαμβανει τραμαδολη hci και παρακεταμολη
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations
US11000488B2 (en) 2019-03-22 2021-05-11 Syntrix Biosystems Inc. Treating pain using desmetramadol

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830934A (en) 1967-07-27 1974-08-20 Gruenenthal Chemie Analgesic and antitussive compositions and methods
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US4507323A (en) 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4940731A (en) 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
US5151448A (en) 1991-07-12 1992-09-29 Crenshaw Roger T Method for treating premature ejaculation
ATE169498T1 (de) 1991-09-06 1998-08-15 Mcneilab Inc Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
ZW14392A1 (en) 1991-09-06 1994-05-11 Mcneilab Inc "Compositions comprising a tramadol material and any of codeine, oxycodone or bydrocodone and their use"
US5223541A (en) 1991-09-13 1993-06-29 Mcneilab, Inc. Tramadol n-oxide material, enantiomers and compositions thereof, and their use
US5516803A (en) * 1991-10-30 1996-05-14 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5276042A (en) 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
IT1264965B1 (it) 1993-11-12 1996-10-17 Giorgio Cavallini Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601745C1 (de) 1996-01-19 1997-10-09 Gruenenthal Gmbh Verfahren zur Racematspaltung von Tramadol
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19609847A1 (de) 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
IL119121A (en) 1996-08-22 2000-11-21 Chemagis Ltd Process for the purification of (RR-SS)-2-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexanol hydrochloride
DE19641576C1 (de) 1996-10-09 1998-05-07 Gruenenthal Gmbh Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten
US5919826A (en) 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
WO1998046216A1 (fr) * 1997-04-11 1998-10-22 Nippon Shinyaku Co., Ltd. Traitements des mictions frequentes et de l'incontinence urinaire
US6399618B1 (en) 1997-07-09 2002-06-04 Cardiome Pharma Corp Compositions and methods for modulating sexual activity
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6037360A (en) 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5922341A (en) 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6156342A (en) 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
GB2340037A (en) 1998-07-30 2000-02-16 Glaxo Group Ltd Compositions comprising bupropion for the treatment of premature ejaculation
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
AU3894600A (en) 1999-03-19 2000-10-09 Knoll Pharmaceutical Company Method of treating sexual dysfunction
AU4982300A (en) 1999-05-06 2000-11-21 Pentech Pharmaceuticals, Inc. Regimen and kit for amelioration of premature ejaculation
DE122009000036I2 (de) 1999-09-03 2010-05-06 Apbi Holdings Llc Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
US6339105B1 (en) 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
WO2001034125A2 (en) * 1999-11-09 2001-05-17 Darwin Discovery Limited Therapeutic use and formulation of (-)-tramadol
WO2001059084A1 (en) 2000-02-11 2001-08-16 Eli Lilly And Company Protein c derivatives
US6369051B1 (en) 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
CN1289071C (zh) * 2001-03-16 2006-12-13 Dmi生物科学公司 曲马朵物质在制备用于延缓男性射精的药物中的用途

Similar Documents

Publication Publication Date Title
JP2004532828A5 (ja)
EP2298416A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
JP2006526031A5 (ja)
JP2008516004A5 (ja)
JP2007514005A5 (ja)
CA2429844A1 (en) Mch antagonists and their use in the treatment of obesity
HUP0401714A2 (hu) Propiverin vagy gyógyászatilag elfogadható sóinak nyújtott hatóanyag-eladású, orális adagolási formái
JP2003531118A5 (ja)
JP2006502187A5 (ja)
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
WO2003005968A3 (en) Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
JP2005504782A5 (ja)
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors
JP2004500426A5 (ja)
JP2011527333A5 (ja)
RS54050B1 (en) FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS
HUP0401569A2 (hu) Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra
JP2005509503A5 (ja)
RU2003100507A (ru) Фармацевтические композиции
CA2529604A1 (en) Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
WO2005004915A3 (en) Compositions comprising meloxicam
JP2006516141A5 (ja)
EP2020233A3 (en) Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
HK1075894A1 (en) Prucalopride-n-oxide
EP1201240A3 (en) Heterocyclic derivatives useful as pharmaceutical agents